BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 23097128)

  • 21. Clinical and imaging description of the Maron subtypes of hypertrophic cardiomyopathy.
    Reant P; Donal E; Schnell F; Reynaud A; Daudin M; Pillois X; Dijos M; Landelle M; Peyrou J; Cornolle C; Laurent F; Montaudon M; Roudaut R; Lafitte S
    Int J Cardiovasc Imaging; 2015 Jan; 31(1):47-55. PubMed ID: 25421460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional left ventricular myocardial contraction abnormalities and asynchrony in patients with hypertrophic cardiomyopathy evaluated by magnetic resonance spatial modulation of magnetization myocardial tagging.
    Mishiro Y; Oki T; Iuchi A; Tabata T; Yamada H; Abe M; Onose Y; Ito S; Nishitani H; Harada M; Taoka Y
    Jpn Circ J; 1999 Jun; 63(6):442-6. PubMed ID: 10406583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in the extent of fibrosis in obstructive and nonobstructive hypertrophic cardiomyopathy.
    Avegliano G; Politi MT; Costabel JP; Kuschnir P; Trivi M; Ronderos R
    J Cardiovasc Med (Hagerstown); 2019 Jun; 20(6):389-396. PubMed ID: 30994509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
    Ho CY; Abbasi SA; Neilan TG; Shah RV; Chen Y; Heydari B; Cirino AL; Lakdawala NK; Orav EJ; González A; López B; Díez J; Jerosch-Herold M; Kwong RY
    Circ Cardiovasc Imaging; 2013 May; 6(3):415-22. PubMed ID: 23549607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between intraventricular myocardial systolic dyssynchrony and ventricular arrhythmias in patients with hypertrophic cardiomyopathy.
    D'Andrea A; Caso P; Severino S; Scotto di Uccio F; Vigorito F; Ascione L; Scherillo M; Calabrò R
    Echocardiography; 2005 Aug; 22(7):571-8. PubMed ID: 16060893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of left ventricular systolic and diastolic abnormalities in patients with hypertrophic cardiomyopathy using real-time three-dimensional echocardiography and two-dimensional speckle tracking imaging.
    Huang X; Yue Y; Wang Y; Deng Y; Liu L; Di Y; Sun S; Chen D; Fan L; Cao J
    Cardiovasc Ultrasound; 2018 Oct; 16(1):23. PubMed ID: 30285887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extent of late gadolinium enhancement at right ventricular insertion points in patients with hypertrophic cardiomyopathy: relation with diastolic dysfunction.
    Zhu Y; Park EA; Lee W; Kim HK; Chu A; Chung JW; Park JH
    Eur Radiol; 2015 Apr; 25(4):1190-200. PubMed ID: 25597022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left-ventricular mechanics in children with hypertrophic cardiomyopathy. CMR study.
    Mazurkiewicz Ł; Ziółkowska L; Petryka J; Śpiewak M; Małek Ł; Kubik A; Marczak M; Misko J; Brzezińska-Rajszys G
    Magn Reson Imaging; 2017 Nov; 43():56-65. PubMed ID: 28688952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of left ventricular twist mechanics by speckle tracking echocardiography reveals association between LV twist and myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Zhang HJ; Wang H; Sun T; Lu MJ; Xu N; Wu WC; Sun X; Wang WG; Lin QW
    Int J Cardiovasc Imaging; 2014 Dec; 30(8):1539-48. PubMed ID: 25106760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy.
    Maron MS
    J Cardiovasc Transl Res; 2009 Dec; 2(4):415-25. PubMed ID: 20560000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.
    Maron MS; Maron BJ; Harrigan C; Buros J; Gibson CM; Olivotto I; Biller L; Lesser JR; Udelson JE; Manning WJ; Appelbaum E
    J Am Coll Cardiol; 2009 Jul; 54(3):220-8. PubMed ID: 19589434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left Atrial Performance in the Course of Hypertrophic Cardiomyopathy: Relation to Left Ventricular Hypertrophy and Fibrosis.
    Kowallick JT; Silva Vieira M; Kutty S; Lotz J; Hasenfu G; Chiribiri A; Schuster A
    Invest Radiol; 2017 Mar; 52(3):177-185. PubMed ID: 27741021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of left ventricular systolic function in hypertrophic cardiomyopathy patients with myocardial injury: a study based on layer-specific speckle tracking echocardiaography.
    Liu W; Zhang Y; Liu Y; Ma C; Yang J; Sun D
    Int J Cardiovasc Imaging; 2020 Nov; 36(11):2129-2137. PubMed ID: 32602022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Young patients with hypertrophic cardiomyopathy, but not subjects at risk, show decreased myocardial perfusion reserve quantified with CMR.
    Gyllenhammar T; Fernlund E; Jablonowski R; Jögi J; Engblom H; Liuba P; Arheden H; Carlsson M
    Eur Heart J Cardiovasc Imaging; 2014 Dec; 15(12):1350-7. PubMed ID: 25139907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advanced myocardial characterization in hypertrophic cardiomyopathy: feasibility of CMR-based feature tracking strain analysis in a case-control study.
    Yang L; Zhang L; Cao S; Gao C; Xu H; Song T; Zhang X; Wang K
    Eur Radiol; 2020 Nov; 30(11):6118-6128. PubMed ID: 32588208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum cardiac troponin I is related to increased left ventricular wall thickness, left ventricular dysfunction, and male gender in hypertrophic cardiomyopathy.
    Kubo T; Kitaoka H; Okawa M; Yamanaka S; Hirota T; Hoshikawa E; Hayato K; Yamasaki N; Matsumura Y; Yasuda N; Sugiura T; Doi YL
    Clin Cardiol; 2010 Feb; 33(2):E1-7. PubMed ID: 20043329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered regional myocardial velocities by tissue phase mapping and feature tracking in pediatric patients with hypertrophic cardiomyopathy.
    Li A; Ruh A; Berhane H; Robinson JD; Markl M; Rigsby CK
    Pediatr Radiol; 2020 Feb; 50(2):168-179. PubMed ID: 31659403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic implications of global myocardial mechanics in hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking. Relations to left ventricular hypertrophy and fibrosis.
    Hinojar R; Fernández-Golfín C; González-Gómez A; Rincón LM; Plaza-Martin M; Casas E; García-Martín A; Fernandez-Mendez MA; Esteban A; Nacher JJJ; Zamorano JL
    Int J Cardiol; 2017 Dec; 249():467-472. PubMed ID: 29121751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracellular volume fraction is more closely associated with altered regional left ventricular velocities than left ventricular ejection fraction in nonischemic cardiomyopathy.
    Collins J; Sommerville C; Magrath P; Spottiswoode B; Freed BH; Benzuly KH; Gordon R; Vidula H; Lee DC; Yancy C; Carr J; Markl M
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.